An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in Japan
Clinical trial NCT06156982 · COMPLETED
Trial details
- NCT number
- NCT06156982
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-06
- Primary completion
- 2024-01-09
- Enrollment
- 397
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.